Exelixis Inc [EXEL] stock is trading at $33.67, up 0.36%. An important factor to consider is whether the stock is rising or falling in short-term value. The EXEL shares have gain 2.25% over the last week, with a monthly amount glided 1.42%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Exelixis Inc [NASDAQ: EXEL] stock has seen the most recent analyst activity on January 27, 2025, when Morgan Stanley upgraded its rating to a Overweight and also boosted its price target to $40 from $30. Previously, Oppenheimer downgraded its rating to Perform on January 24, 2025. On December 20, 2024, downgrade downgraded it’s rating to Market Perform and revised its price target to $40 on the stock. BofA Securities downgraded its rating to a Neutral and increased its price target to $39 on December 17, 2024. RBC Capital Mkts reiterated its recommendation of a Outperform and raised its price target to $34 on October 16, 2024. UBS started tracking with a Neutral rating for this stock on September 19, 2024, and assigned it a price target of $30. In a note dated April 11, 2024, Barclays downgraded an Equal Weight rating on this stock but restated the target price of $25.
Exelixis Inc [EXEL] stock has fluctuated between $20.01 and $37.59 over the past year. Currently, Wall Street analysts expect the stock to reach $33.17 within the next 12 months. Exelixis Inc [NASDAQ: EXEL] shares were valued at $33.67 at the most recent close of the market. An investor can expect a potential drop of -1.49% based on the average EXEL price forecast.
Analyzing the EXEL fundamentals
Exelixis Inc [NASDAQ:EXEL] reported sales of 2.08B for the trailing twelve months, which represents a growth of 14.33%. Gross Profit Margin for this corporation currently stands at 0.96% with Operating Profit Margin at 0.25%, Pretax Profit Margin comes in at 0.29%, and Net Profit Margin reading is 0.22%. To continue investigating profitability, this company’s Return on Assets is posted at 0.16, Equity is 0.21 and Total Capital is 0.2. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.09.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 33.39 points at the first support level, and at 33.12 for the second support level. However, for the 1st resistance point, the stock is sitting at 33.91, and for the 2nd resistance point, it is at 34.15.
Ratios To Look Out For
For context, Exelixis Inc’s Current Ratio is 3.93. On the other hand, the Quick Ratio is 3.88, and the Cash Ratio is 0.66. Considering the valuation of this stock, the price to sales ratio is 4.62, the price to book ratio is 4.23 and price to earnings (TTM) ratio is 21.46.
Transactions by insiders
Recent insider trading involved Hessekiel Jeffrey, EVP & General Counsel, that happened on Nov 29 ’24 when 60000.0 shares were sold. Officer, JEFFREY HESSEKIEL completed a deal on Nov 29 ’24 to buy 60000.0 shares. Meanwhile, EVP, Commercial Haley Patrick J. sold 10000.0 shares on Nov 22 ’24.
